Stephen W. Potter

Insider Reports History

Identity 1 fact
Location
Columbia, MD
SEC filing record 1 fact
SEC signature
/s/ Stacie Aarestad, Attorney-in-fact
SEC evidence 1 fact
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Stephen W. Potter:

Form 4 holding Chief Business Officer

APPLIED GENETIC TECHNOLOGIES CORP

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
30 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stephen W. Potter

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .